GST may lead to drug shortage; chemists not keeping stock: Kiran Mazumdar-Shaw, Biocon Ruby Khatun Khatun2 July 2017 9:36 AM ISTNew Delhi: Biotech major Biocon Chairman and Managing Director Kiran Mazumdar-Shaw today cautioned of possible drug shortage after implementation of...
FITPASS raises 1 million dollar through Abhinav Bindra Ruby Khatun Khatun1 July 2017 5:48 PM ISTNew Delhi: FITPASS, an all-access pass to gyms and fitness studios, has raised USD 1 million through India's only individual Olympic gold medallist...
No price change in 78 percent of actively used drugs post GST: NPPA Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: Drug pricing regulator NPPA on Friday said prices of around 78 per cent of 'actively used' drugs will remain unaffected after the rollout...
Unichem Labs gets EIR from USFDA for Goa facility Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: Drug firm Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulatorfor the company's plant at...
AstraZeneca Pharma India appoints Gagan Singh Bedi as MD Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: Drug firm AstraZeneca Pharma India on Thursday said Gagan Singh Bedi will take over as the Managing Director of the company with effect...
Zydus Cadila gets USFDA nod to market anti-obesity drug Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Phentermine Hydrochloride orally disintegrating tablets...
Dr Harsh Vardhan launches National Biopharma Mission Ruby Khatun Khatun1 July 2017 4:07 PM ISTNew Delhi: The first ever Industry-Academia mission to accelerate biopharmaceutical development in the country was formally launched by Union Science...
Fortis Healthcare gets shareholders nod to hike FIIs shareholding limit to 74 percent Ruby Khatun Khatun30 Jun 2017 1:07 PM ISTNew Delhi: Fortis Healthcare said its shareholders have approved increasing shareholding limit for foreign institutional investors to up to 74 per...
Eris Lifesciences shares gain 1.5% in debut trade Ruby Khatun Khatun30 Jun 2017 11:45 AM ISTNew Delhi: Shares of Eris Lifesciences rose by 1.5 per cent over the issue price of Rs 603 in its debut trade today.The stock listed at Rs 612, up...
New form of Roche's Esbriet approved in Europe for lung disorder Ruby Khatun Khatun30 Jun 2017 11:45 AM ISTRoche said a new Esbriet tablet formulation was approved in Europe for mild to moderate idiopathic pulmonary fibrosis (IPF), a fatal condition that...
AstraZeneca, Chi-Med take kidney cancer drug into final testing Ruby Khatun Khatun30 Jun 2017 11:45 AM ISTAstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib...
Delhi High Court to hear pharma firms plea on fixed dose drugs ban Ruby Khatun Khatun30 Jun 2017 11:44 AM ISTThe Delhi High Court will today hear the plea filed by several pharmaceutical companies that sought a stay of a central government notification that...